Skin explant model of human graft-versus-host disease: Prediction of clinical outcome and correlation with biological risk factors

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 2, 2006, Pages 152-159

  Wang, Xiao Nong ^a   Collin, Matthew ^a   Sviland, Lisbet ^b   Marshall, Scott ^a   Jackson, Graham ^c   Schulz, Ute ^d   Holler, Ernst ^d   Karrer, Sigrid ^d   Greinix, Hildegard ^e   Elahi, Fariborz ^e   Hromadnikova, Ilona ^f   Dickinson, A M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplant; Skin explant model

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOIMMUNITY; ARTICLE; CELLULAR IMMUNITY; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CORRELATION ANALYSIS; EUROPE; EXPLANT; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HLA MATCHING; HLA TYPING; HODGKIN DISEASE; HUMAN; IMMUNOPATHOLOGY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PREDICTION; RISK FACTOR; SIBLING; SKIN TRANSPLANTATION; T CELL DEPLETION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SKIN;

EID: 31344481792     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.09.018     Document Type: Article

References (30)

1. M. Theobald T. Nierle D. Bunjes et al. Host specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings N Engl J Med 327 1992 1613-1617
2. R.J. Soiffer R. Gonin C. Murray et al. Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation Blood 82 1993 2216-2223
3. J. Cavet A.M. Dickinson J. Norden P.R. Taylor G.H. Jackson P.G. Middleton Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation Blood 98 2001 1594-1600
4. G. Cavanagh C.E. Chapman V. Carter A.M. Dickinson P.G. Middleton Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation Transplantation 79 2005 602-605
5. S. Scholl H.G. Sayer L.O. Mugge et al. Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation J Cancer Res Clin Oncol 130 2004 704-710
6. M. Hirayama E. Azuma T. Kumamoto et al. Prediction of acute graft-versus-host disease and detection of distinct end-organ targets by enumeration of peripheral blood cytokine spot-forming cells Transplantation 80 2005 58-65
7. G.B. Vogelsang A.D. Hess A.W. Berkman et al. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants N Engl J Med 313 1985 645-650
8. A.M. Dickinson L. Sviland X.N. Wang et al. Predicting graft-versus-host disease in HLA-identical bone marrow transplants: A comparison of T cell frequency analysis and a human skin explant model Transplantation 66 1998 857-863
9. L. Sviland A.M. Dickinson A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation J Clin Pathol 52 1999 910-913
10. A.M. Dickinson L. Sviland J. Dunn P. Carey S.J. Proctor Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model Bone Marrow Transplant 7 1991 209-216
11. A.M. Dickinson X.N. Wang L. Sviland et al. In situ dissection of graft-versus-host and graft-versus-leukemia effects by minor histocompatibility antigen specific cytotoxic T cells Nat Med 8 2002 410-414
12. A.M. Dickinson L. Sviland P.J. Hamilton et al. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients Bone Marrow Transplant 13 1994 65-70
13. X.N. Wang C. Lange U. Schulz et al. IL-10 modulation of alloreactivity and graft-versus-host-reactions Transplantation 74 2002 772-778
14. C.C. Hofmeister A. Quinn K.R. Cooke et al. Graft-versus-host disease of the skin: Life and death on the epidermal edge Biol Blood Marrow Transplant 10 2004 366-372
15. H. Glucksberg R. Storb A. Fefer et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors Transplantation 18 1974 295-304
16. M. Mielcarek P.J. Martin W. Leisenring et al. Graft-versus-host disease after nonmyeloablative versus conventional haematopoietic stem cell transplantation Blood 102 2003 756-762
17. A.M. Dickinson L. Sviland P. Carey et al. Skin explant culture as a model for cutaneous graft-versus-host disease in humans Bone Marrow Transplant 3 1988 323-329
18. L. Sviland A.M. Dickinson P.J. Carey A.D. Pearson S.J. Proctor An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients Bone Marrow Transplant 5 1990 105-109
19. K.G. Lerner G.F. Kao R. Storb C.D. Buckner R.A. Clift E.D. Thomas Histopathology of graft-vs-host reaction (GvHR) in human recipients of marrow from HLA-matched sibling donors Transplant Proc 6 1974 367-371
20. S.S.B. Randolph T.A. Gooley E.H. Warren F.R. Appelbaum S.R. Riddell Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA matched, related haematopoietic stem cell transplants Blood 103 2004 347-352
21. R.A. Nash M.S. Pepe R. Storb et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate Blood 80 1992 1838-1845
22. R. Wong S.A. Giralt T. Martin et al. Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years Blood 102 2003 3052-3059
23. A. Shimoni N. Kroger T. Zabelina et al. Hematopoietic stem cell transplantation from unrelated donors in elderly patients (age > 55 years) with hematologic malignancies: Older age is no longer a contraindication when using reduced intensity conditioning Leukemia 19 2005 7-12
24. J. Aschan O. Ringden Prognostic factor for long-term survival in leukaemia marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease Clin Transplant 8 1994 258-270
25. A.M. Dickinson I. Hromadnikova L. Sviland et al. Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants-effect of GVHD prophylaxis Bone Marrow Transplant 24 1999 857-863
26. N. Kroger T. Zabelina W. Kruger et al. In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors Bone Marrow Transplant 29 2002 683-689
27. S. Chakrabarti K. Robinson S. Peggs et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation Blood 96 2000 2419-2425
28. X.N. Wang L. Sviland A.J. Ademokun et al. Cellular alloreactivity of human cord blood cells detected by T cell frequency analysis and a human skin explant model Transplantation 66 1998 903-909
29. H. Klingemann R. Storb A. Fefer et al. Bone marrow transplantation in patients aged 45 years and older Blood 67 1986 770-776
30. P.N. Martins J. Pratschke A. Pascher et al. Age and immune response in organ transplantation Transplantation 79 2005 127-132